An interventional study of Motivational interviewing in Chronic Obstructive Pulmonary Disease (COPD), sponsored by Zealand University Hospital. Completed at 1 site in Denmark. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Zealand University Hospital · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 243 studies in Pulmonary Disease, Chronic Obstructive with a site in Denmark — 33 open to participants now, 42 under way, 8 of them phase 3. Pulmonary Disease, Chronic Obstructive · Denmark.
Among the 243 studies in Pulmonary Disease, Chronic Obstructive with a site in Denmark, this one is the 195th largest by enrollment of the 209 interventional ones that give a count, is one of 13 that started in 2025, is one of 84 with no phase, and was the 223rd registered.
5,522 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 856 are open to participants now.
Browse Pulmonary Disease, Chronic Obstructive studies →33 of the 243 studies in Pulmonary Disease, Chronic Obstructive with a site in Denmark are open now. Recruiting first, the newest first:
Chronic Obstructive Pulmonary Disease Trial Network, Denmark · Sites in Denmark
Ages 18+
Eli Lilly and Company · Sites in Denmark, United States, Argentina and 15 more countries
Ages 40–75
Nordsjaellands Hospital · Sites in Denmark
Ages 18+
Vejle Hospital · Sites in Denmark
Ages 50+
Steno Diabetes Center Copenhagen · Sites in Denmark
Ages 18+
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 558 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 29 take children under 18; 88 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
243 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 27 · Phase 3 61 · Phase 4 35
First in 1999; this study’s year is marked. 13 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 11 is below the median of 62 across 3,841 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.
Median enrollment 182 across the 209 interventional studies, 197 across the 34 observational. Of the 172 that completed or were terminated, 74 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
111 of 243 have an industry lead sponsor. The 10 most frequent:
Zealand University Hospital is the lead sponsor of 237 studies on the registry; 50 are open to participants now.
Zealand University Hospital has 2 studies filed under Pulmonary Disease, Chronic Obstructive — fewer than ten, so there is no comparison to draw.
14 of the studies in Pulmonary Disease, Chronic Obstructive with a site in Denmark that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05878769Phase 3Hoffmann-La RocheA Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) | 2027-06-30 |
| NCT07555483Phase 3Grifols Therapeutics LLCA Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD) | 2027-09-30 |
| NCT06163131Aarhus University HospitalThe Effect of Treatment of Emphysema With Endobronchial Valves on the Diaphragm Mobility | 2026-11-27 |
| NCT06677593Copenhagen University Hospital, HvidovreDetection of Electrodermal Activity in Pain 2 | 2026-12-01 |
| NCT07428785Copenhagen University Hospital, RigshospitaletPulmonary and Total Blood Volume in COPD | 2026-12-20 |
Add all 14 to your calendar (.ics) → With an account.
Among the 243 studies in Pulmonary Disease, Chronic Obstructive with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This intervention development and pilot study aimed to develop and evaluate a nurse-led motivational intervention designed to reduce sedentary behavior among patients with severe chronic obstructive pulmonary disease (COPD).
A total of 11 patients were enrolled. The intervention consisted of an individualized, home-based counseling session delivered by a trained nurse, integrating principles of Motivational Interviewing (MI) and Cognitive Behavioral Therapy (CBT). The intervention focused on identifying individual barriers, strengthening motivation, and establishing realistic, patient-centered goals to reduce sedentary time in everyday life.
The pilot study explored the acceptability and practical application of the intervention from both patient and nurse perspectives. Sedentary behavior was objectively assessed using thigh-worn accelerometers over seven consecutive days, alongside patient-reported outcome measures and evaluations of the intervention experience.
Findings from the study informed further refinement of the intervention, its delivery, and the outcome assessment procedures in preparation for a subsequent randomized controlled trial (RCT).
This intervention development and pilot study aimed to develop and evaluate a nurse-led motivational intervention targeting sedentary behavior in patients with severe chronic obstructive pulmonary disease (COPD).
Patients with severe COPD often experience breathlessness, fatigue, and functional limitations that contribute to prolonged sedentary time. High levels of sedentary behavior may negatively affect physical functioning, health outcomes, and quality of life. Although pulmonary rehabilitation is an important component of COPD management, some patients experience barriers to participation, including symptom burden, physical limitations, and fear of worsening breathlessness. Individually tailored behavioral interventions may offer an additional approach to supporting patients in reducing sedentary behavior through manageable changes in daily routines.
The intervention was developed to support individualized behavioral change and incorporated principles from Motivational Interviewing (MI) and Cognitive Behavioral Therapy (CBT). It was designed to be delivered by trained nurses and to address patients' individual needs, preferences, capabilities, and everyday circumstances.
The pilot study included 11 patients with severe COPD recruited from a pulmonary outpatient setting. Participants were offered an individualized, nurse-led counseling session in their own homes. During the session, the nurse explored the patient's current sedentary behavior, perceived barriers to movement, personal motivations, and opportunities for change. Together, the nurse and patient identified realistic and meaningful goals aimed at interrupting prolonged sitting and incorporating additional movement into everyday activities. The intervention emphasized achievable behavioral adjustments rather than structured exercise, recognizing the physical limitations and symptom burden associated with severe COPD.
Sedentary behavior was objectively assessed using a thigh-worn accelerometer over seven consecutive days. Patient-reported outcome measures were also collected to characterize participants' health status and symptom burden. These assessments provided information about the target population and the practical considerations associated with data collection.
The pilot evaluation focused on the acceptability, relevance, and practical delivery of the intervention. Patient feedback was collected to explore experiences of the counseling session, perceived relevance of the individualized goals, and barriers to behavioral change. The nurse delivering the intervention also evaluated its applicability in clinical practice, including the counseling structure, patient engagement, and practical considerations related to intervention delivery.
Additional aspects of the evaluation included recruitment, participant retention, adherence to accelerometer measurements, and the acceptability and burden of patient-reported outcome assessments. These findings were used to identify potential improvements to intervention materials, counseling procedures, and data collection methods.
The study provided preliminary insights into the implementation and acceptability of a nurse-led behavioral intervention targeting sedentary behavior in patients with severe COPD. As a small, single-arm pilot study, it was not designed to establish intervention effectiveness. Instead, the findings informed further development and refinement of the intervention and the methodological procedures for a subsequent randomized controlled trial (RCT).
The overall objective is to develop a clinically relevant, patient-centered nursing intervention that can support sustainable reductions in sedentary behavior among individuals living with severe COPD.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This feasibility study involves a single-arm intervention where patients with severe COPD receive nurse-led motivational interviews to reduce sedentary behavior. Participants recieve one 60 minute intervention, focusing on identifying barriers, setting small activity goals, and building motivation using motivational interviewing (MI) and Cognitive Behavioral Therapy (CBT) techniques. Participants wear accelerometers for seven days before the intervention to measure changes in sedentary time. The study assesses recruitment feasibility, adherence, and patient acceptability, informing refinements before a future randomized controlled trial (RCT).
Behavioral: Motivational interviewing
This intervention consists of a single nurse-led motivational interview aimed at reducing sedentary behavior in patients with severe COPD. The session, conducted in the patient's home, lasts approximately 60 minutes and focuses on identifying personal barriers, exploring motivation, and setting small, realistic goals to reduce sedentary time. Unlike traditional pulmonary rehabilitation, this intervention does not involve structured exercise but instead uses motivational interviewing (MI) techniques to encourage gradual behavior change in daily routines. Before the intervention, patients wear an accelerometer for seven days to objectively measure baseline sedentary time. The study assesses feasibility, patient engagement, and adherence to determine whether the approach is suitable for a larger randomized controlled trial (RCT).
Feasibility and acceptability of the intervention
Measured by the number of participants who successfully complete the intervention.
Time frame: From enrollment to one week post-intervention
questionnaire
Measured by the number of participants who successfully complete the provided questionnaire SF-12
Time frame: From enrollment to one week post-intervention
questionnaire
Measured by the number of participants who successfully complete the provided questionnaire CRQ
Time frame: From enrollment to one week post-intervention
questionnaire
Measured by the number of participants who successfully complete the provided questionnaire HADS.
Time frame: From enrollment to one week post-intervention
Ran from Mar 2025 to primary completion in Jun 2026, 14 months.
Of 1,095 non-industry interventional studies with no phase under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 14 months is below that.
Counting every sponsor, half of 1,183 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Jul 2027 → Jun 2026 and completion Jul 2027 → Jun 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pulmonary Disease, Chronic Obstructive →